Clinical Trials Logo

Clinical Trial Summary

Serious concern about the role of anesthesia in tumor recurrence has considerably risen over years, but the lack of surrogate markers for tumor spreading made trials addressing this issue difficult to realize. In breast cancer patients CTC positivity has been recently recognized as an independent prognostic factor. In this respect, we postulated that in a first step changes in the number of CTC after general anesthesia would help to determine the effect of anesthesia on this tumor marker.


Clinical Trial Description

Patients with primary breast cancer will be randomized to either propofol or sevoflurane anesthesia for curative surgery. CTC will be determined in the pre- as well as postoperative phase and the kinetic of CTC in the two groups will be compared. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02005770
Study type Interventional
Source University of Zurich
Contact
Status Completed
Phase Phase 4
Start date March 2014
Completion date April 2018

See also
  Status Clinical Trial Phase
Recruiting NCT02243163 - Effect of Yoga on Life Quality and Immunity in Breast Cancer Patients After Operation and or Chemotherapy N/A
Completed NCT04290585 - Technology and Health Communication in Improving Health Outcomes in Patients Scheduled for Mammography N/A
Terminated NCT02540330 - A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant Phase 2
Completed NCT01643148 - The Tetrad BMI, Leptin, Leptin/Adiponectin (L/A) Ratio and CA-15-3 is a Reliable Biomarker of Breast Cancer N/A
Active, not recruiting NCT02942355 - Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer Phase 2